Utah Medical Products (UTMD)
NASDAQ:UTMD
Want to see UTMD full AI Analyst Report?
UTMD Stock Chart & Stats
$55.67
-$0.06(-0.11%)
At close: 4:00 PM EST
$55.67
-$0.06(-0.11%)
Day’s Range― - ―
52-Week Range$52.00 - $71.81
Previous CloseN/A
Volume4.21K
Average Volume (3M)15.88K
Market Cap
$211.58M
Enterprise Value$124.38M
Total Cash (Recent Filing)$87.41M
Total Debt (Recent Filing)$210.00K
Price to Earnings (P/E)19.5
Beta0.60
Next Earnings
Jul 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.15%
Share Statistics
EPS (TTM)3.30
Shares Outstanding3,184,025
10 Day Avg. Volume20,525
30 Day Avg. Volume15,884
Financial Highlights & Ratios
PEG Ratio-1.18
Price to Book (P/B)1.55
Price to Sales (P/S)4.81
P/FCF Ratio12.93
Enterprise Value/Market Cap0.59
Enterprise Value/Revenue3.31
Enterprise Value/Gross Profit6.18
Enterprise Value/Ebitda8.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetNear-zero leverage and minimal debt versus a sizable equity base give the company durable financial flexibility. This conservatism lowers bankruptcy risk, supports capital allocation (buybacks, capex, M&A) and cushions shocks, strengthening resilience over the next 2–6 months and beyond.
High And Sustainable MarginsSustained gross and net margins well above peers indicate enduring pricing power and efficient operations. High margins support reinvestment, R&D and distributor relationships, enabling durable profitability even if top-line growth slows, preserving long-term cash generation capacity.
Strong Cash ConversionNearly one-to-one free cash flow to net income demonstrates high-quality earnings and dependable cash generation. This reliable conversion supports sustainable dividends, working capital needs and strategic initiatives, providing a durable foundation for shareholder returns and operational stability.
Bears Say
Persistent Revenue DeclineMulti-year top-line contraction erodes scale, limits operating leverage and constrains long-term growth options. Persistent revenue declines reduce ability to invest in new products or expand channels, increasing reliance on margin and cost control to sustain earnings over the medium term.
Softening Free Cash Flow TrendWhile cash conversion remains high, a roughly 9% TTM decline in free cash flow signals weakening operational cash generation. Continued FCF shrinkage would limit reinvestment, reduce the buffer for unexpected costs, and pressure capital returns or strategic spending over the coming months.
Concentrated End MarketsConcentration in obstetrics, gynecology and neonatal niches creates dependence on procedure volumes, hospital budgets and reimbursement trends. Limited product diversification raises exposure to sector-specific headwinds, constraining secular growth potential and amplifying risk from demand shifts.
Utah Medical Products News
UTMD FAQ
What was Utah Medical Products’s price range in the past 12 months?
Utah Medical Products lowest stock price was $52.00 and its highest was $71.81 in the past 12 months.
What is Utah Medical Products’s market cap?
Utah Medical Products’s market cap is $211.58M.
When is Utah Medical Products’s upcoming earnings report date?
Utah Medical Products’s upcoming earnings report date is Jul 28, 2026 which is in 58 days.
How were Utah Medical Products’s earnings last quarter?
Utah Medical Products released its earnings results on Apr 23, 2026. The company reported $0.818 earnings per share for the quarter, beating the consensus estimate of N/A by $0.818.
Is Utah Medical Products overvalued?
According to Wall Street analysts Utah Medical Products’s price is currently Overvalued.
Does Utah Medical Products pay dividends?
Utah Medical Products pays a Quarterly dividend of $0.31 which represents an annual dividend yield of 2.15%. See more information on Utah Medical Products dividends here
What is Utah Medical Products’s EPS estimate?
Utah Medical Products’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Utah Medical Products have?
Utah Medical Products has 3,184,025 shares outstanding.
What happened to Utah Medical Products’s price movement after its last earnings report?
Utah Medical Products reported an EPS of $0.818 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.528%.
Which hedge fund is a major shareholder of Utah Medical Products?
Currently, no hedge funds are holding shares in UTMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Utah Medical Products Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
UTMD Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 78.1K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.23%
12-Months-Change
Fundamentals
Return on Equity
9.13%
Trailing 12-Months
Asset Growth
1.52%
Trailing 12-Months
Company Description
Utah Medical Products
Utah Medical Products, Inc. (UTMD) is a leading medical device company focused on developing and manufacturing high-quality medical products primarily for the healthcare sector. Founded in 1978 and headquartered in Midvale, Utah, the company specializes in the design of innovative, proprietary products that cater to the needs of hospitals and healthcare professionals. UTMD's product lines include disposable devices used in critical areas such as neonatal care, urology, and surgical procedures, emphasizing safety and efficacy.
Technical Analysis
Ownership Overview
0.69% Insiders
17.29% Mutual Funds
27.37% Other Institutional Investors
42.38% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---